![Cecil B. Pickett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cecil B. Pickett
Direttore/Membro del Consiglio presso
Yumanity, Inc.
Profilo
Cecil B. Pickett is currently a Director at Yumanity, Inc., a Member of the National Academy of Sciences, and a Member of the National Academy of Medicine.
Previously, he was a Director-Molecular Pharmacology & Biochemistry at Merck & Co., Inc., Senior Vice President at Schering-Plough Corp., President-Research & Development at Biogen, Inc., and President & Senior Vice President at Schering-Plough Research Institute.
He was also an Independent Director at Zimmer Biomet Holdings, Inc., Director at Purdue Pharma LP, Director & President-Research & Development at Biogen Idec, Inc. (North Carolina), Director at Yumanity Holdings LLC, Director at Zimmer US, Inc., and Independent Director at Yumanity Therapeutics, Inc. He holds a doctorate from the University of California, Los Angeles and an undergraduate degree from California State University-East Bay.
Posizioni attive di Cecil B. Pickett
| Società | Posizione | Inizio |
|---|---|---|
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | 08/04/2009 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Cecil B. Pickett
| Società | Posizione | Fine |
|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/03/2018 |
| BIOGEN INC. | Direttore Tecnico/Scientifico/R&S | 12/03/2009 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Presidente | 01/10/2009 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/10/2009 |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Presidente | 01/09/2006 |
Formazione di Cecil B. Pickett
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
83
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Zimmer Biomet Holdings, Inc.
 Zimmer Biomet Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes orthopedic reconstructive implants | Health Technology |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California State University-East Bay
 California State University-East Bay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
Yumanity Holdings LLC
 Yumanity Holdings LLC Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Zimmer US, Inc.
 Zimmer US, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes orthopaedic reconstructive implants | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
